TScan Therapeutics, Inc 10-K for FY2025
TScan Therapeutics, Inc. (TCRX)
10-K
2026-03-04
For: 2025-12-31
View Original
Added on
April 06, 2026
About this 10-K
TScan Therapeutics, Inc filed this 10-K on March 4, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $10.33M
- up 266.7% from $2.82M a year earlier
- Net loss
- $129.77M
- compared with a net loss of $127.5M a year earlier
- Diluted EPS
- -$1.00
- compared with -$1.14 a year earlier